Shuttle Pharmaceuticals Holdings, Inc. Uncategorized Contracts & Agreements

29 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Change Order, dated January 23, 2025, between Shuttle Pharmaceuticals, Inc. and Theradex Systems, Inc
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2025
Sponsored Research Agreement, dated December 16, 2024, by and among Shuttle Pharmaceuticals Holdings, Inc., the Regents of the University of California and Dr. Robert Flavell
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
CA
2024
Form of Pre-Funded Warrants
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
NY
2024
Form of Common Warrants
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
NY
2024
Form of Common Warrants
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2024
Work Order, dated August 8, 2024, between Shuttle Pharmaceuticals, Inc. and Theradex Systems, Inc
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2024
Amendment Agreement, dated August 6, 2024, between Shuttle Pharmaceuticals Holdings, Inc., Shuttle Pharmaceuticals, Inc. and Alto Opportunity Master Fund, SPC Segregated Master...
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2024
Amendment No. 1 to the Amendment Agreement, dated June 4, 2023, by and between Shuttle Pharmaceuticals Holdings, Inc., Shuttle Pharmaceuticals, Inc. and Alto Opportunity Master...
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2023
Amendment Agreement, dated May 10, 2023, by and between Shuttle Pharmaceuticals Holdings, Inc., Shuttle Pharmaceuticals, Inc. and Alto Opportunity Master Fund, SPC Segregated...
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2023
Material Transfer Agreement, dated March 21, 2023, between Shuttle Pharmaceuticals, Inc. and Georgetown University
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2023
Research Agreement, dated March 16, 2023, between Shuttle Pharmaceuticals, Inc. and Georgetown University
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2023
Letter Agreement, dated March 11, 2023, between Shuttle Pharmaceuticals Holdings, Inc. and Alto Opportunity Master Fund, SPC Segregated Portfolio B, as Collateral Agent
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2023
Amended and Restated Insider Trading Policy, effective March 10, 2023
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2023
Form of Director Letter Agreement
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
DE
2023
Form of Director Offer Letter
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
DE
2022
Manufacturing Agreement, dated September 14, 2022, between Shuttle Pharmaceuticals, Inc. and TCG GreenChem, Inc
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2022
First Amendment to Non-Disclosure, Evaluation and Option Agreement, dated November 30, 2019, between Shuttle Pharmaceutical, Inc. and University of Virginia Licensing & Ventures...
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2022
Non-Disclosure, Evaluation and Option Agreement, dated May 30, 2019, between Shuttle Pharmaceuticals, Inc. and University of Virginia Licensing & Ventures Group
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2022
Director Offer Letter, dated December 2, 2020, between Chris Senanayake and Shuttle Pharmaceuticals Holdings, Inc
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2022
SBIR Phase II Contract #75N9101C00031, dated September 6, 2019, between Shuttle Pharmaceuticals, Inc. and National Institute of Health National Cancer Institute
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2022
SBIR Contract #HHSN261201800016C/75N91018C00016 Agreement between Shuttle Pharmaceuticals, LLC and National Institute of Health National Cancer Institute
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2022
Sublicense Agreement, dated February 15, 2019, between Shuttle Pharmaceuticals Inc. and Propagenix, Inc
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2022
Subaward Agreement dated October 28, 2014 between Shuttle Pharmaceuticals, LLC and LifeSpan/Rhode Island Hospital
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2022
Form of Letter Agreement with Director
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
DE
2022
Material Transfer Agreement, dated April 25, 2017, between Shuttle Pharmaceuticals, Inc. and George Washington University
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2022
SBIR Contract #HHSN261600038C dated September 19, 2016 between Shuttle Pharmaceuticals, LLC. and National Institute of Health National Cancer Institute
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2022
SBIR Contract #HHSN261201600027C, dated September 19, 2016, between Shuttle Pharmaceuticals, LLC and National Institute of Health National Cancer Institute
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2022
SBIR Contract #HHSN261201400013C Amendment of Solicitation/Modification of Contract, dated August 3, 2015, between Shuttle Pharmaceuticals, LLC and National Institute of Health...
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2022
SBIR Contract #HHSN261201400013C, dated September 19, 2014, between Shuttle Pharmaceuticals, LLC and National Institute of Health National Cancer Institute
Shuttle Pharmaceuticals Holdings, Inc.
Biotechnology
2022